170 related articles for article (PubMed ID: 33634016)
41. Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network.
Wei L; Gu W; Hu L; Wang K; Huang H; Shen Y
Crit Rev Eukaryot Gene Expr; 2022; 32(6):57-68. PubMed ID: 35997118
[TBL] [Abstract][Full Text] [Related]
42. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
Ye Y; Gu B; Wang Y; Shen S; Huang W
J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
[TBL] [Abstract][Full Text] [Related]
43. Long Non-Coding RNA DARS-AS1 Contributes to Prostate Cancer Progression Through Regulating the MicroRNA-628-5p/MTDH Axis.
Fan H; Hou J; Liu S; Xiao Z; Cui J
Cancer Manag Res; 2020; 12():8363-8377. PubMed ID: 32982430
[TBL] [Abstract][Full Text] [Related]
44. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
[TBL] [Abstract][Full Text] [Related]
46. lncRNA
Wu F; Zhang W; Wei H; Ma H; Leng G; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):649-660. PubMed ID: 36786074
[TBL] [Abstract][Full Text] [Related]
47. Mechanism underlying the regulation of lncRNA ACTA2-AS1 on CXCL2 by absorbing miRNA-532-5p as ceRNA in the development of ovarian cancer.
Li Y; Yang Z; Chen J
Int J Clin Exp Pathol; 2021; 14(5):596-607. PubMed ID: 34093945
[TBL] [Abstract][Full Text] [Related]
48. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
49. Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression.
Deng J; Zhang Q; Lu L; Fan C
Cancer Manag Res; 2020; 12():2947-2960. PubMed ID: 32431541
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
51. LncRNA PTOV1-AS2 Promotes Colon Cancer Progression through the miR-145-5p/FSCN1 Axis.
Zhang Z; Wu H; Chen Z; Li G; Guo J
J Oncol; 2023; 2023():1298312. PubMed ID: 36960218
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
[TBL] [Abstract][Full Text] [Related]
53. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
54. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
55. RPARP-AS1/miR125a-5p Axis Promotes Cell Proliferation, Migration and Invasion in Colon Cancer.
Ren Y; Zhao C; He Y; Min X; Xu H; Hu X
Onco Targets Ther; 2021; 14():5035-5043. PubMed ID: 34675548
[TBL] [Abstract][Full Text] [Related]
56. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
Wu F; Gao H; Liu K; Gao B; Ren H; Li Z; Liu F
Onco Targets Ther; 2019; 12():657-667. PubMed ID: 30705594
[TBL] [Abstract][Full Text] [Related]
57. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
58. ZFPM2-AS1 transcriptionally mediated by STAT1 regulates thyroid cancer cell growth, migration and invasion via miR-515-5p/TUSC3.
Ren R; Du Y; Niu X; Zang R
J Cancer; 2021; 12(11):3393-3406. PubMed ID: 33976749
[No Abstract] [Full Text] [Related]
59. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis.
Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
Hum Cell; 2020 Apr; 33(2):416-426. PubMed ID: 32072565
[TBL] [Abstract][Full Text] [Related]
60. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
